GILEAD SCIENCES, INC.

Q2 2025 13F Holdings

  • Location
    foster city, CA
  • Num holdings

    14

  • Value ($000)

    $1,280,205

  • Date Filed
    08/14/2025
  • Form type
    13F-HR
  • CIK
    0000882095
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
GLPG
GLPG

GALAPAGOS NV

SPON ADR
36315X101
$467.64 M
37 %

16,707,477

ACLX
ACLX

ARCELLX INC

COMMON STOCK
03940C100
$442.56 M
35 %

6,720,803

RCUS
RCUS

ARCUS BIOSCIENCES INC

COM
03969F109
$255.80 M
20 %

31,424,760

ASMB
ASMB

ASSEMBLY BIOSCIENCES INC

COM NEW
045396207
$40.04 M
3 %

2,209,471

TNGX
TNGX

TANGO THERAPEUTICS INC

COM
87583X109
$24.85 M
2 %

4,854,443

---

MERUS N V

COM
N5749R100
$23.80 M
2 %

452,527

KYTX
KYTX

KYVERNA THERAPEUTICS INC

COM
501976104
$12.67 M
1 %

4,126,119

XLO
XLO

XILIO THERAPEUTICS INC

COM
98422T100
$6.19 M
1 %

9,105,451

HOOK
HOOK

HOOKIPA PHARMA INC

COM NEW
43906K209
$2.35 M
0 %

1,875,945

LPTX
LPTX

LEAP THERAPEUTICS INC

COM NEW
52187K200
$1.58 M
0 %

5,319,148

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 14